Towards Safer Transfusions: Supreme Court Reviews Mandatory Nucleic Acid Testing in Blood Banks

Why in News ?

The Supreme Court of India has agreed to examine whether the Nucleic Acid Test (NAT) should be made compulsory across blood banks to ensure safer blood transfusion practices.

The matter arose from a petition filed by an NGO arguing that access to safe blood forms part of the fundamental right to life under Article 21 of the Constitution. The Court has sought additional data on cost-effectiveness, feasibility, and State-level implementation before taking a final decision.

Background of the Case

The petition contends that:

• Safe and infection-free blood transfusion is integral to the right to life under Article 21.
• NAT is more sensitive and reliable than traditional screening methods.
• Mandatory nationwide implementation is necessary to prevent transfusion-transmitted infections (TTIs).

The Bench has directed the petitioner to file an affidavit detailing:

• Number of hospitals currently using NAT
• States where NAT is operational
• Cost implications for nationwide rollout

This indicates a data-driven judicial approach balancing public health imperatives with fiscal feasibility.

What is the Nucleic Acid Test (NAT) ?

NAT is an advanced molecular diagnostic technique that detects the genetic material (DNA or RNA) of viruses in donated blood.

Key Features

• Detects infections such as:
  • Human Immunodeficiency Virus (HIV)
  • Hepatitis B
  • Hepatitis C
• Reduces the “window period” — the time between infection and detectability.
• Offers higher sensitivity than conventional serological tests.

Comparison with Existing Screening Methods

Currently, most Indian blood banks rely on:

• Enzyme-Linked Immunosorbent Assay (ELISA) tests

While ELISA is cost-effective, it may fail to detect infections during early stages. NAT significantly reduces this risk, thereby enhancing blood safety.

Public Health Context and Recent Incidents

The issue has gained urgency following reported cases of children contracting HIV allegedly due to contaminated blood transfusions in States such as Madhya Pradesh and Jharkhand.

Vulnerability of Thalassemia Patients

Thalassemia is an inherited blood disorder in which the body cannot produce adequate haemoglobin.

• Patients require frequent blood transfusions.
• India has a high burden of thalassemia cases.

For such patients, even a small lapse in screening can result in life-threatening infections.

These incidents have been described as “preventable tragedies,” renewing debate over the adequacy of existing blood safety mechanisms.

Constitutional Dimension and Right to Life

Article 21 guarantees the right to life and personal liberty. Over the years, the Supreme Court has expanded its scope to include:

• Right to health
• Access to medical care
• Protection of human dignity

The petitioner argues that safe blood transfusion falls within this constitutional protection.

The Court’s willingness to examine the matter signals recognition of the intersection between public health governance and fundamental rights.

Policy and Regulatory Framework

Blood safety in India is regulated under:

• The Drugs and Cosmetics Act, 1940
• Supervision by the National Blood Transfusion Council (NBTC)
• State Blood Transfusion Councils

Currently, mandatory screening includes tests for:

• HIV
• Hepatitis B
• Hepatitis C
• Malaria
• Syphilis

NAT is not uniformly mandated nationwide.

Cost and Feasibility Concerns

During hearings, the Court raised concerns regarding:

• Financial burden on economically weaker States
• Infrastructure requirements
• Availability of trained laboratory personnel

Nationwide implementation would require:

• Upgradation of laboratory infrastructure
• Standardised protocols
• Increased budgetary allocation
• Integration across public and private sectors

The fiscal implications make the issue both a health governance and economic policy question.

Significance of the Issue

1. Strengthening Blood Safety Standards

Mandatory NAT could substantially reduce the risk of transfusion-transmitted infections.

2. Human Rights Perspective

Reinforces the constitutional commitment to safeguarding life and dignity.

3. Health System Modernisation

Encourages adoption of advanced diagnostic technologies in public health infrastructure.

4. Vulnerable Population Protection

Particularly critical for thalassemia patients, trauma victims, and surgical patients.

5. Fiscal-Health Balance

Highlights the challenge of reconciling universal health standards with fiscal constraints.

Challenges and Way Forward

Challenges

• High initial implementation costs
• Uneven healthcare infrastructure across States
• Training and quality control requirements
• Monitoring and compliance issues

Way Forward

• Phased implementation prioritising high-burden States
• Central financial assistance for weaker States
• Public-private partnerships for lab capacity
• Periodic audit and accreditation mechanisms
• Strengthening voluntary blood donation systems